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Abstract
Introduction: High-grade anal intraepithelial neoplasia, also referred to as anal squamous carcinoma in-situ, or
Bowen’s disease of the anus, make up less than 1% of all digestive system cancers in the United States. The
treatment of choice is surgical resection with anal mapping. However, this disease often recurs or persists, requiring
additional surgery for these patients. This can compromise the anal sphincter leading to leakage. In this case
report, we discuss the efficacy of radiation therapy as a modality to treat post-excisional recurrent Bowen’s disease,
which may prevent sphincter compromise, leading to improved quality of life.
Case presentation: An 84-year-old Caucasian woman presented with post-excisional persistent/recurrent
squamous cell carcinoma in-situ. The initial lesion measured 3 cm in diameter on the right lateral side of the anal
margin. A standard surgery consisting of wide local excision with anal mapping was performed. The margins were
clear and our patient was followed up. Our patient recurred with a 1.2 × 0.8 cm lesion on the left anal verge
extending to the anal canal. A biopsy along with mapping was done, and 2 of the 17 mapping specimens were
positive for carcinoma in-situ, one in the anal canal. Due to the location of the positive anal mapping, and in order
to prevent sphincter compromise on re-excision, our patient was offered definitive radiation therapy. Two years
after radiation therapy, our patient showed no signs of recurrent disease and had good sphincter control.
Conclusion: Although the main treatment modality for treating persistent/recurrent Bowen’s disease is surgery, an
alternative approach using external beam radiation for CIS may be enough to provide a cure for some patients
with recurrent disease.
Introduction
Squamous cell carcinoma (SCC) is one of the most
common dermatologic malignancies, typically affecting
sun-exposed surfaces in patients. Although exceedingly
rare, SCC can involve skin hidden from the harmful
effects of ultraviolet (UV) radiation, such as the perianal
region. Additionally, anal SCC is preceded by a pre-
invasive carcinoma such as anal intraepithelial neoplasia
(AIN) which is often assessed and treated prior to
becoming SCC.
Up to 80 percent of AIN cases are believed to develop
from infections from the Human Papilloma Virus (HPV)
16 and 18 [1,2]. HPV E6 and E7 gene products inacti-
vate the mitotic regulator proteins of tumor suppressor
genes (p53 and Rb), thereby permitting malignant trans-
formation [3]. Histologically, AIN I and AIN II involve
less than two-thirds of mucosal thickness and are
considered low-grade lesions [4]. AIN III involves more
than two-thirds of mucosal thickness, and is considered
high-grade (Bowen’s disease), with malignant potential
that warrants treatment [5].
High-grade anal intraepithelial neoplasia is uncommon
and only a handful of cases have been reported [6]. In
this case report, we discuss the efficacy of radiation
therapy as a modality to treat post-excisional persistent/
recurrent anal carcinoma in-situ.
Case presentation
An 83-year-old Caucasian woman originally presented
with a 3 cm anal mass at the 3-o’c l o c kp o s i t i o no ft h e
anal verge. She underwent a wide excision of the mass
with pathology revealing Bowen’s disease with clear
margins six months prior. She was monitored closely on
follow-up every two months. During a re-evaluation
approximately six months after surgery, a 1.2 × 0.8 cm
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any medium, provided the original work is properly cited.lesion was discovered on the left side of her anus verge.
The mass looked similar to the previous lesion on the
right. The lesion had spread into the anal canal. A
biopsy of the mass with anal mapping was performed,
and the mass was consistent with Bowen’s disease. In
addition, 2 of 17 specimens from the anal mapping were
positive for squamous cell carcinoma in-situ, one of
which was in the anal canal. Our patient denied any
abdominal or anal pain, had no abnormal bowel habits.
She stated that she had seen occasional blood stains on
toilet paper, but denied fresh blood per rectum.
Because this was considered a recurrence in an adja-
cent region, it was believed that a repeat wide surgical
excision would leave our patient with a dysfunctional
anal sphincter. For quality of life concerns, additional
local therapeutic options such as topical Fluorouracil (5-
FU) cream and XRT were discussed with our patient.
Since the tumor was in the anal canal, chemotherapy
was not considered her best option. Radiotherapy, on
t h eo t h e rh a n d ,c o u l dd e l i v e rat h e r a p e u t i cd o s eo f
radiation to the entire anus and anal canal with margin.
Our patient agreed and began treatment accordingly.
Our patient was treated with conformal therapy via
the right posterior oblique and left posterior oblique
field to the anus. The field size measured 5.5 × 8.3 cm.
Sixty degree wedges were used to modify the beam, and
customized blocking was used to block out normal tis-
sue. Our patient received 25 fractions at a 180 centigray
(cGy) fraction per day, with a total of 4500 cGy. Our
patient tolerated the XRT well with minimal complaints
and no change in defecation. A physical exam revealed
some mild epidermitis during the course of the XRT,
but she was otherwise free of complications. During fol-
low-up visits, our patient’s perianal irritation resolved.
She maintained normal anal sphincter tone, and had a
complete resolution of her Bowen’s disease. Two years
after the radiation treatments, our patient is disease free,
with good anal sphincter control.
Discussion
Although surgical excision remains the gold standard in
the treatment of anal squamous carcinoma in-situ,
radiation therapy should be evaluated as a valid option
for patients with recurrent disease. Nerve injuries,
damage to the anal sphincter, as well as disease recur-
rence are the main complications following surgical
excision of anal tumors. One study showed that the
incidence of local recurrence following wide local exci-
sion with margins greater than 1 cm was 23.1 percent
[7]. Less than 1 cm margins result in worse recurrence
rates (53.3 percent) and cases of progression to invasive
carcinoma. Furthermore, with HPV-16 and HPV-18
making up 50 and 20 percent of all HPV infections
respectively [8], the risk of developing recurrent disease
with surgery alone is high. Even with anal mapping and
negative margins, anal carcinoma can recur in HPV
positive regions.
Because of the morbidity and the high recurrence
rates associated with surgical resection of high-grade
anal intraepithelial neoplasia, radiotherapy may be a
good option for patients with recurrent disease. A single
institution case report by Herat et al. in 2006 showed
local recurrence of high-grade Bowen’si na nH I Vp o s i -
tive patient six months after treatment with 5-FU and
5200 cGy over 30 fractions of radiation [9]. The case
report by Herat et al., however, differs from our report
because our patient is HIV negative and was initially
treated with surgical excision and negative margins.
Local radiation to the tumor bed in our patient has
shown to be effective in a number of ways. Not only did
our patient have an improved quality of life with a func-
tional anal sphincter, but more importantly has had no
recurrence of the disease nearly two years after the
radiation treatments.
Conclusion
Carcinoma in-situ of the anus is uncommon, and there
is not much support in the literature for treatment
options besides surgery. Our case report focuses on a
patient who received solely radiation therapy to treat
her recurrent carcinoma in-situ, with positive results.
Our patient was treated with a total of 4500 cGy over
25 fractions and tolerated the treatment well. On a 2-
year follow up, our patient not only showed no signs of
recurrence of the disease, but also preserved her normal
anal sphincter function. In patients with carcinoma in-
situ, radiation therapy alone can be enough to success-
fully treat recurrent disease, while limiting the adverse
effects that may result from surgery or chemotherapy.
Consent
Written informed consent was obtained from our
patient for publication of this case report and accompa-
nying images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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